2
项与 Pegloprastide 相关的临床试验An Open-Label, Single-Arm, Phase 2 Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery
Phase 2, open-label study of AVB-620 in women with primary, nonrecurrent and nonmetastatic breast cancer undergoing surgery.
A Phase 1 Trial of AVB-620 in Women With Primary, Non-Recurrent Breast Cancer Undergoing Surgery
This is a Phase 1, open-label, dose escalation study in women with primary, non-recurrent breast cancer undergoing surgery. AVB-620 will be administered prior to surgery.
100 项与 Pegloprastide 相关的临床结果
100 项与 Pegloprastide 相关的转化医学
100 项与 Pegloprastide 相关的专利(医药)
100 项与 Pegloprastide 相关的药物交易